Michael Hejna
147 works · 5,214 citations · h-index 37
Top works
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- Endoscopic Ultrasound Guided Therapy of Benign and Malignant Biliary Obstruction: A Case Series
- Combined Irinotecan and Oxaliplatin Plus Granulocyte Colony-Stimulating Factor in Patients With Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer
- Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment
- Inhibition of Metastases by Anticoagulants
- The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature
- Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer
- Palliative chemotherapy for advanced gastric cancer
- The impact of hemoglobin levels on fatigue and quality of life in cancer patients
- Association between Helicobacter pylori Infection and Pancreatic Cancer
- Nonsurgical management of malignant thymoma
- Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
- Antibiotic Treatment Is Not Effective in Patients Infected With Helicobacter pylori Suffering From Extragastric MALT Lymphoma
- Monitoring of Serum Her-2/ neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer
- Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
- Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
- The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
- Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP)
- Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: Results of a phase II trial
- Palliative chemotherapy for recurrent and metastatic esophageal cancer.